Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (271-280 of 400) with videos related to

Pageof 40
Sort By:
Theranostics|July 27, 2017
[<sup>177</sup>Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic AgentMargret Schottelius, Theresa Osl, Andreas Poschenrieder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 21, 2015
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixaforKen Herrmann, Constantin Lapa, Hans-Juergen Wester, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 6, 2022
[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective studyChristian Linz, Roman C Brands, Stephan Hackenberg, et al.
Endocrine|September 13, 2018
Volumetric and texture analysis of pretherapeutic Rudolf A Werner, Ralph A Bundschuh, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Clinical Nuclear Medicine|October 30, 2018
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT ImagingRudolf A Werner, Charles Marcus, Sara Sheikhbahaei, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
The Thoracic and Cardiovascular Surgeon|April 23, 2004
Lymph node staging in lung cancer using [18F]FDG-PETG Halter, A K Buck, H Schirrmeister, et al.
Pageof 40

Showing results (271-280 of 400) with videos related to

Sort By:
Pageof 40
Theranostics|July 27, 2017
[<sup>177</sup>Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic AgentMargret Schottelius, Theresa Osl, Andreas Poschenrieder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 21, 2015
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixaforKen Herrmann, Constantin Lapa, Hans-Juergen Wester, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 6, 2022
[<sup>18</sup>F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective studyChristian Linz, Roman C Brands, Stephan Hackenberg, et al.
Endocrine|September 13, 2018
Volumetric and texture analysis of pretherapeutic Rudolf A Werner, Ralph A Bundschuh, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Clinical Nuclear Medicine|October 30, 2018
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT ImagingRudolf A Werner, Charles Marcus, Sara Sheikhbahaei, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
The Thoracic and Cardiovascular Surgeon|April 23, 2004
Lymph node staging in lung cancer using [18F]FDG-PETG Halter, A K Buck, H Schirrmeister, et al.
Pageof 40